Beam Therapeutics：估值仍具上行空間 (NASDAQ:BEAM)
· seekingalpha.com
Beam Therapeutics (BEAM) 股票展望：基因編輯研發管線、至 2029 年的強勁現金流穩定性，以及保守的估值。
Max is an independent equity research analyst with a primary focus on biotechnology, healthcare, and technology companies. His investment approach is fundamenta...